KS Biomedix Holdings plc

DISCERNA

Instruments and apparatus for the administration of antibody-based therapy and prophylaxis preparations and substances, namely, medical syringes and injectors for medical purposes and gas-powered or spring powered needle free injectors;

DISCERNA

biotechnology services, including development of new technology for others in the field of biotechnology; scientific and medical research and development, including contract research services; medical services; licensing of intellectual property; high throughput screening services; product development consultation, namely advisory services relating to diagnostic products;

TRIOMICS

MULTIMERIC, PARTICULARLY TRIMERIC OR HEXAMERIC PHARMACEUTICAL SUBSTANCES AND PREPARATIONS FOR THE TREATMENT OF CANCER, INFLAMMATORY BOWEL DISEASE, AND INFECTIOUS DISEASES; THERAPEUTIC AND DIAGNOSTIC PROTEINS AND POLYPEPTIDES FOR CLINICAL OR MEDICAL USE; PROTEIN, ANTIBODY, AND POLYPEPTIDE CONJUGATES FOR CLINICAL OR MEDICAL LABORATORY USE; DIAGNOSTIC AND ANALYTICAL PREPARATIONS, NAMELY, RECEPTOR TARGETED CONJUGATES,FUSION PROTEINS, CELL LINES PRODUCING PROTEINS, RADIOACTIVE AND DETECTABLY LABELED PREPARATIONS AND SUBSTANCES, AND IMMUNOGENIC AND ANTIGENIC PROTEINS FOR CLINICAL OR MEDICAL LABORATORY USE;MEDICAL AND VETERINARY SERVICES;BIOTECHNOLOGY SERVICES, NAMELY, THE DEVELOPMENT OF NEW PRODUCTS AND TECHNOLOGIES FOR OTHERS IN THE FIELD OF BIOTECHNOLOGY, SCIENTIFIC RESEARCH AND DEVELOPMENT, CONTRACT BIOCHEMICAL RESEARCH SERVICES FOR OTHERS, LICENSING OF INTELLECTUAL PROPERTY; AND MEDICAL DIAGNOSTIC RESEARCH SERVICES;